Besides the major use of 6-mercaptopurine as an anti-neoplastic agent (Calabresi & Parks, 1975) , it has found additional application as an immunosuppressive (Hitchings & Elion, 1963) and antiinflammatory drug (Page et al., 1962) . Although the mechanism of its anti-neoplastic action (interfering with nucleic acid biosynthesis; Calabresi & Parks, 1975) and of immunosuppression (inhibiting antibody production; Hitchings & Elion, 1963) is well documented, the biochemical basis of its antiinflammatory activity in diseases such as hepatitis (Page et al., 1962) , collagen diseases (Lorenzen & Videbaek, 1965) , ulcerative colitis (Bean, 1966) etc. is not very well explained by the described mechanisms of action.
One of the mechanisms underlying the antiinflammatory action of various drugs has in recent years been explained by the formation of their copper chelates (Elmes, 1974) . However, no such information regarding the anti-inflammatory activity of 6-mercaptopurine being mediated through the formation of its copper chelate is available. Tissue and serum copper concentrations are known to be elevated in malignancy, as well as in inflammatory processes, and are an extremely sensitive indicator of these conditions (Hrgovcic et al., 1973) . Moreover, a with reference to its anti-inflammatory 799 the therapy exists. High copper concentrations are observed in active disease, diminishing with the abatement of the disease in response to the therapy (Hrgovcic et al., 1973; Fleming et al., 1974) . Furthermore it is also reported that the activity of xanthine oxidase (xanthine:oxygen oxidoreductase, EC 1.2.3.2), the enzyme responsible for the metabolism of 6-mercaptopurine, is decreased in neoplastic disorders (Prajda et al., 1976) . The altered activity of this enzyme appears to be characteristic of neoplastic transformations (Weber, 1973) . Cu2+, in addition, is known to be a potent inhibitor of xanthine oxidase (Bergel & Bray, 1959) .
These facts indicate the possibility that an interrelationship between the action of 6-mercaptopurine, Cu2+ and xanthine oxidase could exist under the conditions cited above. In the present study, therefore, we have tried to examine the interaction between them, since no such information is available.
Materials and methods

Chemicals
Xanthine, 6-mercaptopurine and calcium phosphate gel were obtained from Sigma. The absorption spectra of 6-mercaptopurine and 6-mercaptopurine-Cu2+ complex were recorded with a Beckman spectrophotometer, model DU-2400. All cuvettes used had a 1 cm light-path. Stoichiometry Job's (1928) method of continuous variation with equimolar solutions of the reagents was used to determine the stoichiometry of the complex. A number of series of solutions were prepared, each with a different concentration of Cu2+ and 6-mercaptopurine. Since the maximum difference in the absorbance between 6-mercaptopurine and 6-mercaptopurine-Cu2+ complex was observed at 318 nm, this wavelength was used to record the absorbances of the solutions. Absorbance was also recorded for the same number of 6-mercaptopurine solutions, used as blanks, which were prepared under identical conditions except for the addition of the metal. The difference in the absorbance of each of the above solutions and the corresponding blank was plotted against the molar fraction of copper to obtain 'Job's (1928) curves'.
Stability constant
The stability constant (K) was calculated from Job's (1928) curves by the method of Subhrama Rao & Raghav Rao (1955) , by employing the formula: K = ( 1-a)/a2C where C is the total concentration of the complex in nmol/litre and a is the degree of dissociation was calculated by the formula:
where Am is the maximum absorbance obtained from the horizontal portion of the curve, indicating that all reagent is present in the form of chelate. As is the absorbance at the stoichiometric molar ratio of the complex, the total concentration of the complex being equal to the concentration of the reagent.
Results and discussion
Incubation of xanthine oxidase with various concentrations of 6-mercaptopurine produced a slight activation of the enzyme activity at low concentrations of the purine. Control experiments, performed simultaneously in the absence of xanthine, did not reveal any substrate activity of 6-mercaptopurine at these concentrations of the purine. Increasing the concentration of 6-mercaptopurine, however, resulted in the inhibition of the enzyme, as seen from Fig. 1 .
Xanthine oxidase was markedly inactivated by Cu2+ (Fig. 1) . A definite inhibition of the enzyme activity was observed with concentrations of Cu2+ as low as 5 pM, whereas maximal inhibition (96.7%) ' -' -'1 was produced by 5O0UM-CU2+. The Lineweaver-Burk (1934) plots in the absence and presence of Cu2+ revealed the inhibition to be non-competitive. The apparent K1 value calculated from these data was found to be 9 x 1O-6M. Since in our previous work with pyruvate kinase (Vijayvargiya et al., 1970) it was observed that D-penicillamine, a thiol compound with known anti-inflammatory activity, could protect against as well as reverse the inhibition of the enzyme by Cu2+, we tried to examine whether such a relationship holds good or not with 6-mercaptopurine and Cu2+-inhibited xanthine oxidase. Table 1 demonstrates that the addition of 6-mercaptopurine (20,UM) after the addition of low concentrations of Cu2+ (5,UM) led to complete protection of the enzyme against Cu2+ inhibition. 6-Mercaptopurine, however also provided protection of the enzyme against the inhibition produced by higher concentrations of this cation.
The possibility that 6-mercaptopurine treatment could also effect the re-activation of Cu2+-inactivated xanthine oxidase was further investigated. The results (Fig. 2) demonstrate that preincubation of the enzyme for 10min with 2.5-10uM-Cu2+ markedly decreased the activity of xanthine oxidase. When 6-mercaptopurine was added to the incubation mixture, the inhibition observed wtih the lower concentrations of Cu2+ was reversed. 6-Mercaptopurine, however, failed to produce complete reversal of the enzyme inhibition at higher concentrations of Cu2+. The data thus indicate the possibility of irreversible inactivation of the enzyme by copper.
During the course of the above experiments it was observed that, on the addition of 6-mercaptopurine to the reaction mixture containing Cu2+, a spontaneous change from colourless to a yellow colour occurred. This indicated the possibility of complex-formation between 6-mercaptopurine molecules and Cu2+ ions. In order to confirm the formation of the complex, absorption spectra of 6-mercaptopurine and 6-mercaptopurine-Cu2+ complex were compared by recording their absorbance at pH 8.0 between 250 and 350 nm. A characteristic alteration in the absorption spectrum of 6-mercaptopurine was observed when equimolar solutions of 6-mercaptopurine and Cu2+ (as CUS04) were mixed. The maximum absorption by 6-mercaptopurine was observed at 318nm, whereas no such peak could be detected for the complex. Moreover, the absorption by 6-mercaptopurine was much more than that by the 6-mercaptopurine-Cu2+ complex, the maximum difference being at 3 18 nm. The stoichiometry of the complex, as determined by Job's (1928) method of continuous variation with equimolar solutions of the reagents is presented in Fig. 3 . It is evident from these curves that Cu2+ forms a 1: 1 complex with 6-mercaptopurine. The apparent stability constant (log K), as calculated by Subhrama Rao & Raghav Rao's (1955) method is found to be 6.74 (S.E.M. + 0.04).
The effect of the 1: 1 6-mercaptopurine-Cu2+ complex on the enzyme activity was then studied (Table 2 ). Different concentrations of the complex did not produce as large a decrease in the xanthine oxidase activity as did similar concentrations of free Cu2+. The extent of inhibition was similar to that caused by 6-mercaptopurine alone (Fig. 1) .
Our results have revealed Cu2+ to be an inhibitor as well as an inactivator of xanthine oxidase. In addition it exhibited the ability of forming a complex with 6-mercaptopurine. The mechanism by which 6-mercaptopurine protects and reverses copper inhibition of the enzyme activity thus becomes explainable by the process of chelation of Cu2+ ions by the drug. The physiological significance of the inhibition of xanthine oxidase by copper could be interpreted in terms of the regulation of the enzyme activity by the metal. It can further be suggested that the reported decreased xanthine oxidase activity in neoplastic cells (Prajda et al., 1976; Weber, 1973) may be related with the inactivation of the enzyme by the element. Since formation of the copper complex of antiinflammatory drugs has been shown to be associated with the mechanism of their action (Elmes, 1974) , a similar process in the anti-inflammatory action of 6-mercaptopurine can be considered. Moreover, in addition to the described anti-metabolite action of 6-mercaptopurine in neoplastic disorders, it might also aid in the treatment of the disease by chelating copper, as a decrease in the concentration of copper is reported to be an index of the chemotherapeutic benefit of the degree of malignancy (Hrgovcic et al., 1968) . Furthermore, the stability constant of the copper-6-mercaptopurine complex is found to exceed those of several naturally occuring cellular chelators for copper (Bjerrum et al., 1957; Foye, 1961) . The magnitude of the stability constant thus provides a satisfactory indication for the proposed mechanism of action of 6-mercaptopurine as a drug. In conclusion, we believe that the above process can be an additional mechanism of action of 6-mercaptopurine hitherto not described.
